Capricorn Venture Partners

Capricorn Partners NV is an independent pan-European manager of venture capital funds that invest in innovative European companies with technology as a competitive advantage. The investment team of Capricorn is composed of experienced investment managers with deep technology expertise and broad industrial experience. As of Dec 2010 [Quest Management](http://www.crunchbase.com/financial-organization/quest-management-nv) is being merged with and acquired by Capricorn Venture Partners.

Frank Bulens

Partner

Olaf Corper

Investment Manager Quoted Equity and Partner

Katrin Geyskens

Partner

Ludwig Goris

Investment Manager

Marc Lambrechts

Senior Investment Manager

Rob van der Meij

Investment Manager

Jos B. Peeters

Founder and Managing Partner

Johan Reynaert

Investment Manager

Ekaterina Smirnyagina

Partner

Claude Stoufs

Partner and Senior Investment Manager

Past deals in Belgium

Minze Health

Series A in 2024
Minze Health is a Belgian healthech startup that develops digital health solutions for the treatment of urinary tract problems. The company's digital health and remote patient monitoring (RPM) solutions are being used by hospitals, urology practices, and pelvic floor rehabilitation centers worldwide. Minze Health was established in 2015 and is headquartered in Antwerp, Belgium.

Minze Health

Seed Round in 2022
Minze Health is a Belgian healthech startup that develops digital health solutions for the treatment of urinary tract problems. The company's digital health and remote patient monitoring (RPM) solutions are being used by hospitals, urology practices, and pelvic floor rehabilitation centers worldwide. Minze Health was established in 2015 and is headquartered in Antwerp, Belgium.

Sensolus

Venture Round in 2020
Sensolus NV specializes in the design and development of GPS trackers for non-powered assets, providing comprehensive tracking solutions directly from the cloud. Established in 2013 and based in Ghent, Belgium, the company offers a range of low-power, context-aware sensing technologies, including its STICKNTRACK product line. Sensolus combines hardware GPS trackers with a fully integrated cloud application, enabling users to manage and monitor their assets with ease. The company serves various industries, including manufacturing, waste management, cargo transport, logistics, and automotive, focusing on delivering real-time information and maintenance-free asset tracking solutions.

iSTAR Medical

Series C in 2019
iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

Arkite NV

Venture Round in 2019
Arkite NV, founded in 2015 and based in Genk, Belgium, specializes in manufacturing automation products designed to enhance operational efficiency in manufacturing environments. Their flagship product, the Human Interface Mate (HIM), aids operators by providing real-time warnings for incorrect operations and guiding them towards standardized work processes. The company emphasizes the importance of a dedicated team with expertise in industrial engineering, lean thinking, and process innovation. In addition to their product offerings, Arkite provides professional services, including process innovation consultancy, integration services, training, and support during the startup phase. They also assist clients with time studies for technology innovation, knowledge management to improve quality systems, and organizational innovations aimed at reducing throughput times.

icometrix

Series A in 2019
icometrix is a company that specializes in the analysis of brain MRI scans to enhance personalized care for patients with neurological disorders. Founded in 2011 as a spin-off from the universities and university hospitals of Leuven and Antwerp, icometrix is headquartered in Leuven, Belgium, with an additional office in Boston, USA. The company has developed MSmetrix, a tool that identifies brain lesions, measures lesion volume, and assesses whole brain and grey matter volume and atrophy. MSmetrix has received market approval in the EU and several other countries, with FDA clearance pending. icometrix is recognized as a leader in MRI biomarkers for routine clinical practice and is certified in quality management and information security. Additionally, the company provides image analysis services for clinical trials and research studies, utilizing its software-as-a-service model to process large volumes of brain imaging data. This approach aids in advancing research on various neurological conditions, including traumatic brain injury, epilepsy, Alzheimer’s disease, and stroke, by using imaging biomarker outcomes as key endpoints in drug development.

Confo Therapeutics

Series A in 2019
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.

Ngdata

Series C in 2017
NGDATA is a company specializing in data management systems that focus on enhancing customer experience and lifetime value for enterprises. It offers a customer data platform named Lily, which integrates big data management and machine learning technologies to provide real-time insights from diverse data sources. This platform allows businesses to gain a comprehensive view of customer interactions, enabling them to engage more effectively and drive customer loyalty. NGDATA serves various industries, including retail, e-commerce, finance, media, and telecommunications. Headquartered in Ghent, Belgium, the company also has offices in Singapore, Paris, New York City, and San Francisco.

Arkite NV

Venture Round in 2017
Arkite NV, founded in 2015 and based in Genk, Belgium, specializes in manufacturing automation products designed to enhance operational efficiency in manufacturing environments. Their flagship product, the Human Interface Mate (HIM), aids operators by providing real-time warnings for incorrect operations and guiding them towards standardized work processes. The company emphasizes the importance of a dedicated team with expertise in industrial engineering, lean thinking, and process innovation. In addition to their product offerings, Arkite provides professional services, including process innovation consultancy, integration services, training, and support during the startup phase. They also assist clients with time studies for technology innovation, knowledge management to improve quality systems, and organizational innovations aimed at reducing throughput times.

Sensolus

Seed Round in 2017
Sensolus NV specializes in the design and development of GPS trackers for non-powered assets, providing comprehensive tracking solutions directly from the cloud. Established in 2013 and based in Ghent, Belgium, the company offers a range of low-power, context-aware sensing technologies, including its STICKNTRACK product line. Sensolus combines hardware GPS trackers with a fully integrated cloud application, enabling users to manage and monitor their assets with ease. The company serves various industries, including manufacturing, waste management, cargo transport, logistics, and automotive, focusing on delivering real-time information and maintenance-free asset tracking solutions.

Ngdata

Series B in 2017
NGDATA is a company specializing in data management systems that focus on enhancing customer experience and lifetime value for enterprises. It offers a customer data platform named Lily, which integrates big data management and machine learning technologies to provide real-time insights from diverse data sources. This platform allows businesses to gain a comprehensive view of customer interactions, enabling them to engage more effectively and drive customer loyalty. NGDATA serves various industries, including retail, e-commerce, finance, media, and telecommunications. Headquartered in Ghent, Belgium, the company also has offices in Singapore, Paris, New York City, and San Francisco.

Diagenode

Venture Round in 2016
Diagenode is an international life sciences company that develops and commercializes innovative instruments and reagents systems for life science research and molecular diagnostics. Founded in 2003 in Liege (Belgium), Diagenode is a global company, with headquarters in Liege, Belgium and Sparta, NJ, USA. Diagenode also has a local sales office in the United Kingdom to better serve this specific country. Diagenode's customers include leading epigenetics researchers, academic institutions, high-profile genome centers and core labs, life sciences tools companies, molecular diagnostics players, and pharmaceutical and biotechnology companies. Epigenetics Division

iSTAR Medical

Series B in 2016
iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

Ngdata

Series B in 2015
NGDATA is a company specializing in data management systems that focus on enhancing customer experience and lifetime value for enterprises. It offers a customer data platform named Lily, which integrates big data management and machine learning technologies to provide real-time insights from diverse data sources. This platform allows businesses to gain a comprehensive view of customer interactions, enabling them to engage more effectively and drive customer loyalty. NGDATA serves various industries, including retail, e-commerce, finance, media, and telecommunications. Headquartered in Ghent, Belgium, the company also has offices in Singapore, Paris, New York City, and San Francisco.

Ogeda

Series B in 2015
Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that focuses on inventing and developing small molecule drugs that target G-Protein Coupled Receptors (GPCRs). The company's lead product, fezolinetant, is currently in Phase II clinical development for treating women's health disorders. In addition to fezolinetant, Ogeda is developing other small molecules aimed at addressing various therapeutic areas, including inflammatory and autoimmune diseases. Founded in 1994 and formerly known as Euroscreen, Ogeda operates additional facilities in Brussels, Belgium, and Paris, France. The company is a subsidiary of Astellas Pharma Inc. and is supported by prominent investors in the biotechnology sector.

iSTAR Medical

Series A in 2013
iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

Trod Medical

Series B in 2013
Trod Medical S.A. is a medical device manufacturer founded in 2006, with headquarters in Leuven, Belgium, and the Tampa Bay area, USA. The company specializes in innovative ablation technologies, particularly in developing radiofrequency (RF) ablation devices. One of its key products, the EncageTM, is a percutaneous RF device designed to precisely ablate soft tissues, minimizing collateral damage during procedures. This technology is particularly significant in the treatment of prostate cancer, a prevalent condition with approximately 240,000 new cases diagnosed annually in the United States. Traditional treatments often lead to severe side effects, such as erectile dysfunction and urinary incontinence, highlighting the importance of Trod Medical's advancements. The company's devices enable healthcare providers to perform endoscopic surgeries with predictable ablation volumes and reduced tissue damage, aiming to improve patient outcomes in a critical area of medical care.

Ngdata

Series A in 2013
NGDATA is a company specializing in data management systems that focus on enhancing customer experience and lifetime value for enterprises. It offers a customer data platform named Lily, which integrates big data management and machine learning technologies to provide real-time insights from diverse data sources. This platform allows businesses to gain a comprehensive view of customer interactions, enabling them to engage more effectively and drive customer loyalty. NGDATA serves various industries, including retail, e-commerce, finance, media, and telecommunications. Headquartered in Ghent, Belgium, the company also has offices in Singapore, Paris, New York City, and San Francisco.

Trinean

Venture Round in 2012
Trinean is a Belgium-based technology provider that specializes in micro-volume molecular spectroscopy. Founded in 2006 as a spin-out from Ghent University and Imec Leuven, the company develops UV/VIS spectrometers tailored for biomolecule quantification. Its products, the DropSense™16 and DropSense™96, can analyze up to 16 and 96 samples, respectively, utilizing microfluidic chips for standardized sample analysis. These instruments are designed to enhance data interpretation and facilitate laboratory automation, making them valuable tools for biologics researchers. Trinean combines its advanced analytical hardware with a comprehensive software toolbox to optimize the performance of its spectrometers.

EpiGan

Venture Round in 2011
EpiGaN, a Leuven, Belgium-based company that develops Gallium Nitride on Silicon (GaN) on-silicon wafers...

Ducatt

Venture Round in 2010
Ducatt NV is a clean-tech start-up located in Belgium that specializes in the manufacturing of solar glasses. These ultra-clear patterned glasses are designed to enhance the efficiency of solar systems, offering various thicknesses to meet different client needs. Ducatt's products aim to make solar technology more accessible and affordable, contributing to the growing demand for sustainable energy solutions.

iNEWiT

Venture Round in 2008
iNEWiT, an engineering company, engages in identifying, designing, and creating applications and devices for the mobile market. It provides mobile video communication applications; wireless communication technologies, ranging from GPRS/EDGE, over 3G, HSDPA/HSUPA to WiFi, and WiMAX and satellite networks; and plug and play products for the business-to-consumer markets. The company was founded in 2005 and is based in Mechelen, Belgium

Gemidis

Series C in 2006
Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.

TiGenix

Venture Round in 2003
TiGenix NV is a Belgium-based biomedical company specializing in innovative treatments for damaged and osteoarthritic joints. Founded as a spin-off from the Catholic University of Leuven and the University of Ghent, TiGenix leverages regenerative medicine to create durable therapies validated through controlled clinical studies. The company focuses on developing a portfolio of products aimed at addressing specific musculoskeletal issues, with a primary emphasis on cartilage damage, which significantly impairs patient mobility and function. TiGenix also explores the anti-inflammatory properties of stem cells to create novel therapies for serious medical conditions, particularly in areas where there is a high unmet medical need.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.